MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin.

Background/aims: Ovarian cancer is one of the most common malignancies with a high rate of mortality in women. However, current therapies for ovarian cancer treatment are ineffective. Therefore, novel target identification is an urgent requisite.